WallStSmart

Churchill Capital Corp XI (CCXI)vsGigCapital9 Corp. Class A Ordinary Share (GIX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

GIX leads profitability with a 0.0% profit margin vs 0.0%. GIX earns a higher WallStSmart Score of 26/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

GIX

Avoid

26

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 5.0Quality: 5.8
Piotroski: 2/9Altman Z: 38.95

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

GIX1 strengths · Avg: 10.0/10
Altman Z-ScoreHealth
38.9510/10

Safe zone — low bankruptcy risk

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$779.80M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

GIX4 concerns · Avg: 3.8/10
Price/BookValuation
10.4x4/10

Trading at 10.4x book value

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$185.84M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : GIX

The strongest argument for GIX centers on Altman Z-Score.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : GIX

The primary concerns for GIX are Price/Book, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

GIX is growing revenue faster at 0.0% — sustainability is the question.

CCXI generates stronger free cash flow (-326,107), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

GIX scores higher overall (26/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

GigCapital9 Corp. Class A Ordinary Share

FINANCIAL SERVICES · SHELL COMPANIES · USA

GigCapital2, Inc. is a blank check company. The company is headquartered in Palo Alto, California.

Want to dig deeper into these stocks?